Natalie S. Nunnally

The Landscape of Candidemia During the Coronavirus Disease 2019 (COVID-19) Pandemic

Emma E. Seagle, Brendan R. Jackson, Shawn R. Lockhart et al. · Clinical Infectious Diseases · 2021 · 132 citations · Full text

<i>In Vitro</i> Activity of Ibrexafungerp, a Novel Glucan Synthase Inhibitor against Candida glabrata Isolates with <i>FKS</i> Mutations

Natalie S. Nunnally, Kizee A. Etienne, David Angulo et al. · Antimicrobial Agents and Chemotherapy · 2019 · 61 citations · Full text

Detection of TR ₃₄ /L98H <i>CYP51A</i> Mutation through Passive Surveillance for Azole-Resistant Aspergillus fumigatus in the United States from 2015 to 2017

Elizabeth L. Berkow, Natalie S. Nunnally, Alex Bandea et al. · Antimicrobial Agents and Chemotherapy · 2018 · 52 citations · Full text

In Vitro Activity of Novel Antifungal Olorofim against Filamentous Fungi and Comparison to Eight Other Antifungal Agents

Ourania Georgacopoulos, Natalie S. Nunnally, Eric M. Ransom et al. · Journal of Fungi · 2021 · 44 citations · Full text

Genomic Diversity of Azole-Resistant Aspergillus fumigatus in the United States

Kizee A. Etienne, Elizabeth L. Berkow, Lalitha Gade et al. · mBio · 2021 · 41 citations · Full text